Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeNYSE:PFE

      NYSE:PFE

      Pfizer Stock 2025 Outlook: Potential for Long-Term Growth
      Investing News

      Pfizer Stock 2025 Outlook: Potential for Long-Term Growth

      February 16, 2024
      Pfizer Surprises with 4th Quarter Profit, but Key Products Fall Short in Sales
      Investing News

      Pfizer Surprises with 4th Quarter Profit, but Key Products Fall Short in Sales

      January 30, 2024
      Pfizer’s Investors’ Confidence Dampens Due Bleak 2024 Outlook 
      Investing News

      Pfizer’s Investors’ Confidence Dampens Due Bleak 2024 Outlook 

      December 15, 2023
      Pfizer Stock Tumbles Due to 2024 COVID Expectations Reset
      Investing News

      Pfizer Stock Tumbles Due to 2024 COVID Expectations Reset

      December 13, 2023
      How to Secure a 7% Discount on PFE or Attain a 16% Annual Return
      Investing News

      How to Secure a 7% Discount on PFE or Attain a 16% Annual Return

      December 5, 2023
      Pfizer’s 3Q Earnings Hit by Declining Sales of COVID-19 Products
      Investing News

      Pfizer’s 3Q Earnings Hit by Declining Sales of COVID-19 Products

      November 1, 2023
      3 Resilient Stocks to Safeguard Your Portfolio Amidst October’s Market Volatility
      Trading Tips

      3 Resilient Stocks to Safeguard Your Portfolio Amidst October’s Market Volatility

      October 4, 2023
      Pfizer Stock: Is it a Buy Near 52-Week Lows for its 5.08% Yield?
      Investing News

      Pfizer Stock: Is it a Buy Near 52-Week Lows for its 5.08% Yield?

      September 28, 2023
      Pfizer’s Novel Multiple Myeloma Treatment Elrexfio Secures FDA Approval 
      Investing News

      Pfizer’s Novel Multiple Myeloma Treatment Elrexfio Secures FDA Approval 

      August 16, 2023
      Pfizer Eyes Cost Reductions Amid Declining Demand for COVID Products
      Investing News

      Pfizer Eyes Cost Reductions Amid Declining Demand for COVID Products

      August 1, 2023
      1 2 3 … 6 »

       

      LATEST NEWS

      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview
      • Investing News Okta’s Strong Q3 2026 Earnings Boost Shares
      • Investing News American Eagle Q3 2025 Earnings Report

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025